Suppr超能文献

微创经椎间孔腰椎椎体间融合术治疗高度移位型腰椎间盘突出症的手术疗效

Surgical Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion for Highly Migrated Lumbar Disc Herniation.

作者信息

Wang Anqi, Yu Zhengrong

机构信息

Department of Orthopedics, Peking University First Hospital, Beijing, People's Republic of China.

出版信息

J Pain Res. 2021 Jun 4;14:1587-1592. doi: 10.2147/JPR.S303930. eCollection 2021.

Abstract

OBJECTIVE

To describe minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) for highly migrated lumbar disc herniation (LDH) and assess its clinical outcomes.

PATIENTS AND METHODS

This research retrospectively assessed 25 patients who were diagnosed with one-segmental highly migrated LDH and underwent MIS-TLIF in Peking University First Hospital from June 2015 to September 2019. Demographic data, perioperative parameters, complications, recurrence, and surgical outcomes were assessed.

RESULTS

Twelve males and 13 females, with a mean age of 56.68 years old, were involved and the follow-up period was at least one year. The mean operation time was 222.16 minutes, the mean intraoperative hemorrhage was 250.00 mL, and the mean post-operative hospitalization was 5.76 days. The improvements in visual analog scale (VAS) and Oswestry disability index (ODI) were statistically significant. In addition, based on the MacNab criteria, 22 patients (88.0%) acquired satisfactory (good or excellent) results. One patient underwent post-operative epidural hematoma and recovered after evacuation of the hematoma. No recurrence was found.

CONCLUSION

MIS-TLIF is safe and effective and it can provide satisfactory clinical outcomes for highly migrated LDH.

摘要

目的

描述微创经椎间孔腰椎椎间融合术(MIS-TLIF)治疗高度移位型腰椎间盘突出症(LDH)的情况,并评估其临床疗效。

患者与方法

本研究回顾性评估了2015年6月至2019年9月在北京大学第一医院诊断为单节段高度移位型LDH并接受MIS-TLIF手术的25例患者。评估了人口统计学数据、围手术期参数、并发症、复发情况及手术效果。

结果

纳入12例男性和13例女性,平均年龄56.68岁,随访期至少1年。平均手术时间为222.16分钟,平均术中出血量为250.00毫升,平均术后住院时间为5.76天。视觉模拟评分法(VAS)和Oswestry功能障碍指数(ODI)的改善具有统计学意义。此外,根据MacNab标准,22例患者(88.0%)获得满意(良好或优秀)结果。1例患者术后发生硬膜外血肿,血肿清除后恢复。未发现复发情况。

结论

MIS-TLIF安全有效,可为高度移位型LDH提供满意的临床疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cda/8187084/991bd35d5ad9/JPR-14-1587-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验